Vaccination to prevent zoster in the elderly

Epidemiology and Infection

Volumn 135, Issue 6, 2007, Pages 883-886

  Gershon, A A ^a  

^a New York Presbyterian Columbia University Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIVIRUS AGENT; CHICKENPOX VACCINE; HEPATITIS VACCINE; OPIATE; PLACEBO; VARICELLA ZOSTER VACCINE;

ACUPUNCTURE; CELLULAR IMMUNITY; CHICKENPOX; CLINICAL TRIAL; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DERMATITIS HERPETIFORMIS; DRUG COST; DRUG EFFICACY; DRUG ERUPTION; DRUG SAFETY; EDITORIAL; ELDERLY CARE; HERPES ZOSTER; HUMAN; IMMUNIZATION; IMMUNOCOMPROMISED PATIENT; IMMUNOGENICITY; INCIDENCE; INFECTION CONTROL; INJECTION SITE PAIN; LOW DRUG DOSE; NONHUMAN; PAIN ASSESSMENT; PNEUMONIA; POLYMERASE CHAIN REACTION; POSTHERPETIC NEURALGIA; QUALITY ADJUSTED LIFE YEAR; RISK BENEFIT ANALYSIS; VARICELLA ZOSTER VIRUS; VIRUS REACTIVATION; VIRUS STRAIN; AGED; ECONOMICS; MIDDLE AGED;

AGED; AGED, 80 AND OVER; HERPES ZOSTER; HERPES ZOSTER VACCINE; HUMANS; MIDDLE AGED;

EID: 34748911450     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268807008849     Document Type: Editorial

References (11)

1. Gershon A, Takahashi M, Seward J. Varicella vaccine. In: Plotkin S, Orenstein W, eds. Vaccines, 5th edn. Philadelphia, PA: Saunders, 2007 (in press).
2. Berger R, Florent G, Just M. Decrease of the lympho-proliferative response to varicella-zoster virus antigen in the aged. Infection and Immunity 1981; 32: 24-27.
3. Takahashi M, et al. Live vaccine used to prevent the spread of varicella in children in hospital. Lancet 1974; 2: 1288-1290.
4. Levin MJ. Use of varicella vaccines to prevent herpes zoster in older individuals. Archives of Virology (Suppl.) 2001; 17: 151-160.
5. Oxman MN, et al. A vaccine to previent herpes zoster and postherpetic neuralgia in older adults. New England Journal of Medicine 2005; 352: 2271-2284.
6. Dworkin RH, et al. Recommendations for the management of herpes zoster. Clinical Infectious Diseases 2007; 44 (Suppl. 1): S1-S26.
7. Hope-Simpson RE. The nature of herpes zoster: A long term study and a new hypothesis. Proceedings of the Royal Society of Medicine 1965; 58: 9-20.
8. Hope-Simpson RE. Postherpetic neuralgia. Journal of the Royal College of General Practitioners 1975; 25: 571-575.
9. Gershon A, et al. Varicella-zoster virus. In: Murray PR, ed. Manual of Clinical Microbiology, 9th edn. Washington, DC: ASM Press; 2007, pp. 1537-1548.
10. Hornberger J, Robertus K. Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. Annals of Internal Medicine 2006; 145: 317-325.
11. Koplan JP, Harpaz R. Shingles vaccine: Effective and costly or cost-effective? Annals of Internal Medicine 2006; 145: 386-387.